NCT06293287View on ClinicalTrials.gov

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

January 30, 2025

Conditions
Radial Artery Occlusion
Interventions
DRUG

Subcutaneous enoxaparin sodium

Subcutaneous enoxaparin sodium injections at a dose of 4000 Axa IU once daily

DRUG

Placebo

placebo (0.9% saline solution)

Trial Locations (1)

361015

RECRUITING

Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen

All Listed Sponsors
lead

Zhongshan Hospital (Xiamen), Fudan University

OTHER